| Literature DB >> 28898693 |
Will Bailis1, Justin A Shyer1, Michael Chiorazzi1, Richard A Flavell2.
Abstract
The tumor microenvironment presents metabolic constraints to immunosurveiling cells. In this issue of Cancer Cell, Zhang et al. demonstrate that CD8+ TILs reprogram under hypoxic and hypoglycemic conditions, regaining effector function by engaging fatty acid catabolism, which is promoted by fenofibrate and synergistic with immune checkpoint blockade therapy.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28898693 PMCID: PMC6939383 DOI: 10.1016/j.ccell.2017.08.013
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743